Updated from 2:46 p.m. ESTShares of Ligand Pharmaceuticals (LGND - Get Report) were among the worst-performing health-related stocks Thursday after the company delayed the filing of its annual report because its audit committee needs more time to review issues related to the way the company accounts for product sales and returns.
Health Stocks in Motion
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
Every recommendation goes through 3 layers of intense scrutinyquantitative, fundamental and technical analysisto maximize profit potential and minimize risk.
Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.